[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Market Research Report 2016

November 2016 | 102 pages | ID: GA4DFA1802BEN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Production, means the output of Peripheral Transluminal Angioplasty Drug Eluting Balloon

Revenue, means the sales value of Peripheral Transluminal Angioplasty Drug Eluting Balloon

Revenue, means the salies Peripheral Transluminal Angioplasty Drug Eluting Balloon in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
  • Bayer
  • C. R. Bard, Inc.
  • Contego Medical, LLC
  • Eurocor GmbH
  • Micell Technologies, Inc.
  • Neovasc Inc.
  • Rontis AG
  • SurModics, Inc.
  • Vascular Nanotransfer Technologies
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Peripheral Transluminal Angioplasty Drug Eluting Balloon in these regions, from 2011 to 2021 (forecast), like
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on consumption, market share and growth rate of Peripheral Transluminal Angioplasty Drug Eluting Balloon in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Market Research Report 2016

1 PERIPHERAL TRANSLUMINAL ANGIOPLASTY DRUG ELUTING BALLOON MARKET OVERVIEW

1.1 Product Overview and Scope of Peripheral Transluminal Angioplasty Drug Eluting Balloon
1.2 Peripheral Transluminal Angioplasty Drug Eluting Balloon Segment by Type
  1.2.1 Global Production Market Share of Peripheral Transluminal Angioplasty Drug Eluting Balloon by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Peripheral Transluminal Angioplasty Drug Eluting Balloon Segment by Application
  1.3.1 Peripheral Transluminal Angioplasty Drug Eluting Balloon Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Peripheral Transluminal Angioplasty Drug Eluting Balloon Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Peripheral Transluminal Angioplasty Drug Eluting Balloon (2011-2021)

2 GLOBAL PERIPHERAL TRANSLUMINAL ANGIOPLASTY DRUG ELUTING BALLOON MARKET COMPETITION BY MANUFACTURERS

2.1 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production and Share by Manufacturers (2015 and 2016)
2.2 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Peripheral Transluminal Angioplasty Drug Eluting Balloon Manufacturing Base Distribution, Sales Area and Product Type
2.5 Peripheral Transluminal Angioplasty Drug Eluting Balloon Market Competitive Situation and Trends
  2.5.1 Peripheral Transluminal Angioplasty Drug Eluting Balloon Market Concentration Rate
  2.5.2 Peripheral Transluminal Angioplasty Drug Eluting Balloon Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL PERIPHERAL TRANSLUMINAL ANGIOPLASTY DRUG ELUTING BALLOON PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production by Region (2011-2016)
3.2 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production Market Share by Region (2011-2016)
3.3 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Southeast Asia Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL PERIPHERAL TRANSLUMINAL ANGIOPLASTY DRUG ELUTING BALLOON SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Consumption by Regions (2011-2016)
4.2 North America Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL PERIPHERAL TRANSLUMINAL ANGIOPLASTY DRUG ELUTING BALLOON PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production and Market Share by Type (2011-2016)
5.2 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue and Market Share by Type (2011-2016)
5.3 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Price by Type (2011-2016)
5.4 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production Growth by Type (2011-2016)

6 GLOBAL PERIPHERAL TRANSLUMINAL ANGIOPLASTY DRUG ELUTING BALLOON MARKET ANALYSIS BY APPLICATION

6.1 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Consumption and Market Share by Application (2011-2016)
6.2 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL PERIPHERAL TRANSLUMINAL ANGIOPLASTY DRUG ELUTING BALLOON MANUFACTURERS PROFILES/ANALYSIS

7.1 Bayer
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Peripheral Transluminal Angioplasty Drug Eluting Balloon Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Bayer Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 C. R. Bard, Inc.
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Peripheral Transluminal Angioplasty Drug Eluting Balloon Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 C. R. Bard, Inc. Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Contego Medical, LLC
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Peripheral Transluminal Angioplasty Drug Eluting Balloon Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Contego Medical, LLC Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Eurocor GmbH
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Peripheral Transluminal Angioplasty Drug Eluting Balloon Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Eurocor GmbH Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Micell Technologies, Inc.
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Peripheral Transluminal Angioplasty Drug Eluting Balloon Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Micell Technologies, Inc. Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Neovasc Inc.
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Peripheral Transluminal Angioplasty Drug Eluting Balloon Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Neovasc Inc. Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Rontis AG
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Peripheral Transluminal Angioplasty Drug Eluting Balloon Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Rontis AG Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 SurModics, Inc.
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Peripheral Transluminal Angioplasty Drug Eluting Balloon Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 SurModics, Inc. Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Vascular Nanotransfer Technologies
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Peripheral Transluminal Angioplasty Drug Eluting Balloon Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Vascular Nanotransfer Technologies Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview

8 PERIPHERAL TRANSLUMINAL ANGIOPLASTY DRUG ELUTING BALLOON MANUFACTURING COST ANALYSIS

8.1 Peripheral Transluminal Angioplasty Drug Eluting Balloon Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Peripheral Transluminal Angioplasty Drug Eluting Balloon

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Peripheral Transluminal Angioplasty Drug Eluting Balloon Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Peripheral Transluminal Angioplasty Drug Eluting Balloon Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL PERIPHERAL TRANSLUMINAL ANGIOPLASTY DRUG ELUTING BALLOON MARKET FORECAST (2016-2021)

12.1 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue Forecast (2016-2021)
12.2 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production Forecast by Type (2016-2021)
12.4 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Consumption Forecast by Application (2016-2021)
12.5 Peripheral Transluminal Angioplasty Drug Eluting Balloon Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Peripheral Transluminal Angioplasty Drug Eluting Balloon
Figure Global Production Market Share of Peripheral Transluminal Angioplasty Drug Eluting Balloon by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Peripheral Transluminal Angioplasty Drug Eluting Balloon Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Capacity of Key Manufacturers (2015 and 2016)
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Capacity of Key Manufacturers in 2015
Figure Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Capacity of Key Manufacturers in 2016
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production of Key Manufacturers (2015 and 2016)
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production Share by Manufacturers (2015 and 2016)
Figure 2015 Peripheral Transluminal Angioplasty Drug Eluting Balloon Production Share by Manufacturers
Figure 2016 Peripheral Transluminal Angioplasty Drug Eluting Balloon Production Share by Manufacturers
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue Share by Manufacturers
Table 2016 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue Share by Manufacturers
Table Global Market Peripheral Transluminal Angioplasty Drug Eluting Balloon Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Peripheral Transluminal Angioplasty Drug Eluting Balloon Average Price of Key Manufacturers in 2015
Table Manufacturers Peripheral Transluminal Angioplasty Drug Eluting Balloon Manufacturing Base Distribution and Sales Area
Table Manufacturers Peripheral Transluminal Angioplasty Drug Eluting Balloon Product Type
Figure Peripheral Transluminal Angioplasty Drug Eluting Balloon Market Share of Top 3 Manufacturers
Figure Peripheral Transluminal Angioplasty Drug Eluting Balloon Market Share of Top 5 Manufacturers
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Capacity by Regions (2011-2016)
Figure Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Capacity Market Share by Regions (2011-2016)
Figure Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Capacity Market Share by Regions (2011-2016)
Figure 2015 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Capacity Market Share by Regions
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production by Regions (2011-2016)
Figure Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production and Market Share by Regions (2011-2016)
Figure Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production Market Share by Regions (2011-2016)
Figure 2015 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production Market Share by Regions
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue by Regions (2011-2016)
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue Market Share by Regions (2011-2016)
Table 2015 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue Market Share by Regions
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
Table China Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
Table India Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Consumption Market by Regions (2011-2016)
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Consumption Market Share by Regions (2011-2016)
Figure Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Consumption Market Share by Regions
Table North America Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Consumption, Import & Export (2011-2016)
Table Europe Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Consumption, Import & Export (2011-2016)
Table China Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Consumption, Import & Export (2011-2016)
Table Japan Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Consumption, Import & Export (2011-2016)
Table India Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Consumption, Import & Export (2011-2016)
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production by Type (2011-2016)
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production Share by Type (2011-2016)
Figure Production Market Share of Peripheral Transluminal Angioplasty Drug Eluting Balloon by Type (2011-2016)
Figure 2015 Production Market Share of Peripheral Transluminal Angioplasty Drug Eluting Balloon by Type
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue by Type (2011-2016)
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Peripheral Transluminal Angioplasty Drug Eluting Balloon by Type (2011-2016)
Figure 2015 Revenue Market Share of Peripheral Transluminal Angioplasty Drug Eluting Balloon by Type
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Price by Type (2011-2016)
Figure Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production Growth by Type (2011-2016)
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Consumption by Application (2011-2016)
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Consumption Market Share by Application (2011-2016)
Figure Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Consumption Market Share by Application in 2015
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Consumption Growth Rate by Application (2011-2016)
Figure Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Consumption Growth Rate by Application (2011-2016)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Peripheral Transluminal Angioplasty Drug Eluting Balloon Market Share (2011-2016)
Table C. R. Bard, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table C. R. Bard, Inc. Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
Figure C. R. Bard, Inc. Peripheral Transluminal Angioplasty Drug Eluting Balloon Market Share (2011-2016)
Table Contego Medical, LLC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Contego Medical, LLC Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
Figure Contego Medical, LLC Peripheral Transluminal Angioplasty Drug Eluting Balloon Market Share (2011-2016)
Table Eurocor GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eurocor GmbH Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eurocor GmbH Peripheral Transluminal Angioplasty Drug Eluting Balloon Market Share (2011-2016)
Table Micell Technologies, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Micell Technologies, Inc. Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
Figure Micell Technologies, Inc. Peripheral Transluminal Angioplasty Drug Eluting Balloon Market Share (2011-2016)
Table Neovasc Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Neovasc Inc. Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
Figure Neovasc Inc. Peripheral Transluminal Angioplasty Drug Eluting Balloon Market Share (2011-2016)
Table Rontis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Rontis AG Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
Figure Rontis AG Peripheral Transluminal Angioplasty Drug Eluting Balloon Market Share (2011-2016)
Table SurModics, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SurModics, Inc. Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
Figure SurModics, Inc. Peripheral Transluminal Angioplasty Drug Eluting Balloon Market Share (2011-2016)
Table Vascular Nanotransfer Technologies Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Vascular Nanotransfer Technologies Peripheral Transluminal Angioplasty Drug Eluting Balloon Production, Revenue, Price and Gross Margin (2011-2016)
Figure Vascular Nanotransfer Technologies Peripheral Transluminal Angioplasty Drug Eluting Balloon Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Peripheral Transluminal Angioplasty Drug Eluting Balloon
Figure Manufacturing Process Analysis of Peripheral Transluminal Angioplasty Drug Eluting Balloon
Figure Peripheral Transluminal Angioplasty Drug Eluting Balloon Industrial Chain Analysis
Table Raw Materials Sources of Peripheral Transluminal Angioplasty Drug Eluting Balloon Major Manufacturers in 2015
Table Major Buyers of Peripheral Transluminal Angioplasty Drug Eluting Balloon
Table Distributors/Traders List
Figure Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production and Growth Rate Forecast (2016-2021)
Figure Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Revenue and Growth Rate Forecast (2016-2021)
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production Forecast by Regions (2016-2021)
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Consumption Forecast by Regions (2016-2021)
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Production Forecast by Type (2016-2021)
Table Global Peripheral Transluminal Angioplasty Drug Eluting Balloon Consumption Forecast by Application (2016-2021)


More Publications